Back to mobile site

JMP Securities Starts Acrivon Therapeutics Inc (ACRV) at Market Outperform

March 1, 2024 2:02 AM EST Send to a Friend
JMP Securities analyst Silvan Tuerkcan initiates coverage on Acrivon Therapeutics Inc (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login